JPS5059362A - - Google Patents
Info
- Publication number
- JPS5059362A JPS5059362A JP49110412A JP11041274A JPS5059362A JP S5059362 A JPS5059362 A JP S5059362A JP 49110412 A JP49110412 A JP 49110412A JP 11041274 A JP11041274 A JP 11041274A JP S5059362 A JPS5059362 A JP S5059362A
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Epoxy Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19732349024 DE2349024A1 (de) | 1973-09-26 | 1973-09-26 | 6beta,7beta-epoxy-1alpha,2alphamethylen-d-homo-4-pregnen-3,20-dione |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5059362A true JPS5059362A (cg-RX-API-DMAC7.html) | 1975-05-22 |
Family
ID=5894080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP49110412A Pending JPS5059362A (cg-RX-API-DMAC7.html) | 1973-09-26 | 1974-09-25 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3965128A (cg-RX-API-DMAC7.html) |
| JP (1) | JPS5059362A (cg-RX-API-DMAC7.html) |
| AR (1) | AR202946A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU7374074A (cg-RX-API-DMAC7.html) |
| BE (1) | BE820381A (cg-RX-API-DMAC7.html) |
| DD (1) | DD114599A5 (cg-RX-API-DMAC7.html) |
| DE (1) | DE2349024A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK507974A (cg-RX-API-DMAC7.html) |
| FI (1) | FI280574A7 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2244492A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL45629A0 (cg-RX-API-DMAC7.html) |
| LU (1) | LU70985A1 (cg-RX-API-DMAC7.html) |
| NL (1) | NL7412747A (cg-RX-API-DMAC7.html) |
| NO (1) | NO743449L (cg-RX-API-DMAC7.html) |
| SE (1) | SE7412058L (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA746131B (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6022890A (en) * | 1997-11-14 | 2000-02-08 | Merck & Co., Inc. | Immunosuppressant tetracyclic triterpenes |
| WO1999025703A1 (en) * | 1997-11-14 | 1999-05-27 | Merck & Co., Inc. | Immunosuppressant tetracyclic triterpenes |
| EP2332527A3 (en) | 2004-10-20 | 2011-11-16 | Resverlogix Corp. | Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases |
| AU2006275514B2 (en) * | 2005-07-29 | 2012-04-05 | Resverlogix Corp. | Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| DK2118074T3 (en) * | 2007-02-01 | 2014-03-10 | Resverlogix Corp | Compounds for the prevention and treatment of cardiovascular diseases |
| EP2346837B8 (en) | 2008-06-26 | 2015-04-15 | Resverlogix Corporation | Methods of preparing quinazolinone derivatives |
| AU2010204106B2 (en) | 2009-01-08 | 2014-05-08 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular disease |
| CN102427813A (zh) | 2009-03-18 | 2012-04-25 | 雷斯韦洛吉克斯公司 | 新的抗炎剂 |
| EP2421533B1 (en) | 2009-04-22 | 2018-10-17 | Resverlogix Corp. | Novel anti-inflammatory agents |
| EP2773354B1 (en) | 2011-11-01 | 2019-06-12 | Resverlogix Corp. | Oral immediate release formulations for substituted quinazolinones |
| WO2014080291A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Biaryl derivatives as bromodomain inhibitors |
| WO2014080290A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Cyclic amines as bromodomain inhibitors |
| CA2895905A1 (en) | 2012-12-21 | 2014-06-26 | Zenith Epigenetics Corp. | Novel heterocyclic compounds as bromodomain inhibitors |
| EP3268007B1 (en) | 2015-03-13 | 2022-11-09 | Resverlogix Corp. | Compositions and therapeutic methods for the treatment of complement-associated diseases |
-
1973
- 1973-09-26 DE DE19732349024 patent/DE2349024A1/de active Pending
-
1974
- 1974-09-10 IL IL45629A patent/IL45629A0/xx unknown
- 1974-09-23 US US05/508,492 patent/US3965128A/en not_active Expired - Lifetime
- 1974-09-24 DD DD181291A patent/DD114599A5/xx unknown
- 1974-09-24 LU LU70985A patent/LU70985A1/xx unknown
- 1974-09-25 JP JP49110412A patent/JPS5059362A/ja active Pending
- 1974-09-25 SE SE7412058A patent/SE7412058L/ not_active Application Discontinuation
- 1974-09-25 NO NO743449A patent/NO743449L/no unknown
- 1974-09-26 AR AR255786A patent/AR202946A1/es active
- 1974-09-26 NL NL7412747A patent/NL7412747A/xx unknown
- 1974-09-26 AU AU73740/74A patent/AU7374074A/en not_active Expired
- 1974-09-26 DK DK507974A patent/DK507974A/da unknown
- 1974-09-26 FR FR7432429A patent/FR2244492A1/fr not_active Withdrawn
- 1974-09-26 FI FI2805/74A patent/FI280574A7/fi unknown
- 1974-09-26 ZA ZA00746131A patent/ZA746131B/xx unknown
- 1974-09-26 BE BE148933A patent/BE820381A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SE7412058L (cg-RX-API-DMAC7.html) | 1975-03-27 |
| AU7374074A (en) | 1976-04-01 |
| LU70985A1 (cg-RX-API-DMAC7.html) | 1975-03-06 |
| FR2244492A1 (cg-RX-API-DMAC7.html) | 1975-04-18 |
| FI280574A7 (cg-RX-API-DMAC7.html) | 1975-03-27 |
| DK507974A (cg-RX-API-DMAC7.html) | 1975-06-09 |
| DD114599A5 (cg-RX-API-DMAC7.html) | 1975-08-12 |
| NL7412747A (nl) | 1975-04-01 |
| US3965128A (en) | 1976-06-22 |
| IL45629A0 (en) | 1974-11-29 |
| BE820381A (fr) | 1975-03-26 |
| NO743449L (cg-RX-API-DMAC7.html) | 1975-04-28 |
| AR202946A1 (es) | 1975-07-31 |
| ZA746131B (en) | 1975-09-24 |
| DE2349024A1 (de) | 1975-04-10 |